由 Promedicol | 1 月 15, 2024 | ProEclass Surgery
Randomized Trials Describing Lung Inflammation after Pleurodesis with Talc of Varying Particle Size We report two trials describing whether talc pleurodesis with a mean particle size of less than 15 um (“mixed” talc) produces more lung and systemic inflammation than...
由 Promedicol | 1 月 11, 2024 | ProEclass Surgery
Malignant pleural effusion is a common complication of advanced-stage tumors, caused by primary malignant tumors of the pleura or metastasis of malignant tumors to the pleura. Malignant pleural effusion is most commonly secondary to pleural metastasis, with lung...
由 Promedicol | 12 月 7, 2023 | ProEclass Surgery
Malignant pleural effusion (MPE) is a pleural effusion that is caused by a malignant tumor originating in the pleura or by a metastatic malignant tumor from another site that has invaded the pleura. MPE is associated with poor prognosis. Members of the Pleural and...
由 Promedicol | 10 月 16, 2023 | ProEclass Surgery
In patients with cholangiocarcinoma (CC), management of biliary obstruction commonly involves either up-front percutaneous transhepatic biliary drainage (PTBD) or initial endoscopic retrograde cholangiopancreatography (ERCP) with stent placement. The objective of the...
由 Promedicol | 9 月 28, 2023 | ProEclass Surgery
Aim of this study is to describe a multicenter experience on percutaneous transhepatic biliary drainage (PTBD) performed with ultrasound-guidance to access the biliary tree, focusing on safety, effectiveness and radiation dose exposure; differences between right- and...
